1.20Open1.20Pre Close0 Volume0 Open Interest160.00Strike Price0.00Turnover33.27%IV8.62%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier21DDays to Expiry1.20Extrinsic Value100Contract SizeAmericanOptions Type0.1912Delta0.0231Gamma123.68Leverage Ratio-0.0803Theta0.0156Rho23.64Eff Leverage0.0967Vega
ESCO Technologies Stock Discussion
In reaction to earnings/guidance:
• $Planet Labs PBC (PL.US)$ +11.3%, $Core & Main (CNM.US)$ +6.1%, $Regal Rexnord (RRX.US)$ +2% (reaffirms outlook), $Oracle (ORCL.US)$ +1.6%
Other news:
• $Akero Therapeutics (AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos (AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $Catalyst Pharmaceuticals (CPRX.US)$ +7.7...
No comment yet